Westleaf Inc. (TSX-V: WL) (“Westleaf”), is pleased to announce the opening of a Prairie Records cannabis retail operation in Warman, Saskatchewan and that the company has secured an option agreement (the “Option”) to acquire an additional cannabis retail store location in Swift Current. The Option is conditional on provincial regulatory approval of the permit application and the transactions contemplated by the Option. The Swift Current location is expected to be operated under the Prairie Records brand.
Prairie Records is a unique retail experience that celebrates the instinctual relationship of music and cannabis and surrounds the customer with the aesthetic of shopping in a vintage vinyl shop. The Prairie Records store is now open, centrally located in the town of Warman, just north of Saskatoon. The 3,200-square-foot location includes a retail storefront and warehouse space for an e-commerce fulfillment centre to serve the entire Saskatchewan market.
- Launch of the one-of-a-kind cannabis retail experience Prairie Records, and one of ~50 stores planned across Western Canada by the end of 2020;
- The Warman location will serve as the online fulfillment centre for direct to consumer sales across the entire province of Saskatchewan;
- Westleaf now has the option to purchase three additional retail stores in Saskatchewan, two in Saskatoon, and one in Swift Current. All options are conditional on provincial regulatory approval.
“Prairie Records is going to stand out from our competitors as something distinct and will provide the customer with a unique and engaging cannabis retail experience,” said Adam Coates, Chief Commercial Officer with Westleaf. “From the moment you walk through the door the customer will be greeted by a differentiated and inviting approach to cannabis retail.” Coates noted that shopping at a Prairie Records store will invoke the feeling of a retro-record shop, complete with music paraphernalia, curated play lists, and product information being presented on album covers.
“The opening of this Prairie Records location in Saskatchewan represents a significant milestone for Westleaf” said Scott Hurd, President and CEO of Westleaf. “As a vertically integrated cannabis company we are steadfast in our commitment to execute on our plans to have assets across the cannabis value chain. Combined with the cultivation facility under construction near Battleford, Saskatchewan and the extraction, R&D and production centre under construction in Calgary, Alberta, our strategy is rolling out as planned.” Hurd added.
The Warman location is the first Prairie Records store in Saskatchewan and will be followed by two locations in Saskatoon and one location in Swift Current, subject to Westleaf exercising its option to purchase agreements. Customers can expect superior customer service at Prairie Records, staff have undergone extensive training to ensure they can meet the diverse needs of every consumer who walks through the door while providing a safe, inclusive environment rooted in cannabis education. Prairie Records’ Warman location is located at 100 2nd Ave North and is open Sunday to Thursday from 10 a.m. to 10 p.m. and Friday and Saturday from 10 a.m. to 12 a.m. For more information on Prairie Records, visit prairierecords.ca.
This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. This news release, forward-looking statements relate, among other things, to: (i) regulatory approval of the permit application and the transaction contemplated by the Option Agreement; (ii) the number of prospective Westleaf retail cannabis locations inSaskatchewan; the result and impact of the exercise of the Option, if ever, on Westleaf and its business; (iii) theSaskatchewan cannabis market and Westleaf’s ability to participate therein; (iv) the number of Westleaf retail locations across Canada and the jurisdiction in which it expects to have retail locations; (v) the completion of Westleaf’s facilities, including the timing thereof; and (vi) the business and operations of Westleaf. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; and the delay or failure to receive board, shareholder, court or regulatory approvals. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, Westleaf assume no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.
SOURCE: Westleaf Inc.
Government of Canada takes further steps to address the opioid crisis in British Columbia
The opioid crisis continues to be one of the most serious public health issues in Canada’s recent history. Tragically, between January 2016 and September 2018 more than 10,300 Canadians died from an apparent opioid-related overdose.
Today the Honourable Ginette Petitpas Taylor, Minister of Health, announced funding for new initiatives to increase knowledge about opioid use and treatment, decrease harms associated with opioid use, and enhance access to evidence-based treatment. Minister Petitpas Taylor made the announcement while meeting with representatives of the St. Paul’s Foundation of Vancouver.
New investments totaling $15.3 million announced today include:
- $9.6 million for seven projects that will focus on education and sharing information on effective treatments for opioid use disorder;
- $1.3 million to support four initiatives that will reduce the risk of HIV and hepatitis C among people who share drug use equipment, while also linking people to treatment and support services; and
- $4.4 million to support four research projects to develop innovative, effective treatment options tailored to B.C. communities and Indigenous people.
The funding announced today builds on recent investments to increase access to treatment services for Canadians who are seeking help for problematic substance use. In September 2018, the governments of Canada and British Columbiasigned a bilateral agreement under the Government of Canada’s Emergency Treatment Fund committing more than $71.7 million for innovative and comprehensive treatment options in the province.
“This crisis continues to be one of the most serious public health issues in Canada’s recent history, and organizations on the ground can help us turn the tide of it. That’s why we are investing further in them. We know there is no silver bullet solution to this crisis, and the services and education these organizations offer are crucial. We must continue to work all together to save lives.”
The Honourable Ginette Petitpas Taylor
Minister of Health
“St. Paul’s Hospital happens to sit at the epicentre of the opioid crisis in Vancouver, which has given us both a unique perspective and a profound responsibility. We know that research, outreach, and education will significantly reduce harm, yield financial savings and, most importantly, improve and save the lives of individuals, families, and communities affected by substance use across Canada.”
President and CEO, St. Paul’s Foundation
- Budget 2018 committed more than $230 million over five years to address the opioid crisis. This funding included $150 million for a cost-shared Emergency Treatment Fund.
- Through Budget 2019, the Government of Canada is committing an additional $30.5 million over five years, starting in 2019-20, with $1 million in ongoing funding, for targeted measures to address persistent gaps in harm reduction and treatment.
- Since June 2017, data reported to Health Canada indicate that there have been more than 327,000 visits to supervised consumption sites and overdose prevention sites across Canada, without a single death in the facilities and almost 3,600 reported overdoses reversed.
- Through the Canadian Institutes of Health Research (CIHR), the Government of Canada is investing in researchers who are helping to provide evidence on which interventions work best to prevent opioid overdoses, how to treat opioid use disorder and how to promote harm reduction.
- Health Canada’s Substance Use and Addictions Program (SUAP) provides approximately $50 million annually to support initiatives that help prevent, treat and reduce all forms of harm from problematic substance use, including opioids, cannabis, alcohol and tobacco.
- The Public Health Agency of Canada’s Harm Reduction Fund is investing $7 million annually to support projects across Canada that will help reduce rates of HIV and hepatitis C among people who use drugs.
- The Government of Canada is running a national public awareness campaign on opioids. The campaign aims to raise awareness of the risks associated with opioids, the stigma that prevents people who use drugs from receiving help, and what to do if you witness an opioid overdose.
SOURCE Health Canada
Canada, France, UK launch research workshops exploring societal implications of Artificial Intelligence
CIFAR, in partnership with the the French National Centre for Scientific Research (CNRS) and UK Research and Innovation (UKRI), has launched a series of international AI & Society research workshops to examine the economic, ethical, policy and legal implications of Artificial Intelligence (AI) on society.
As AI technologies become more integrated into daily life through digital assistants and self-driving vehicles, their responsible and ethical development is a pressing concern. The new workshops, set to take place from June 2019 to June 2020 across Canada, France and the UK, will build on international collaborations and bring together perspectives from the social sciences, humanities, law, engineering and computer science as well as policy, business and civil society. The interdisciplinary groups will explore how AI will impact different populations and sectors.
Administered and managed by CIFAR with support from CNRS and UKRI, the workshops explore the global implications of AI on a range of topics – from future conflicts in the Arctic and societal trust in AI systems to how AI may impact the practice of medicine. Each workshop will also produce a non-technical publication with insights for policy-makers in the public and private sectors as well as the public. The eight workshops were carefully selected after a three-month adjudication process. Each workshop will receive up to CAD$50,000 for a total combined commitment of CAD$400,000 from all three organizations for this joint call.
“The strength of these workshops is their interdisciplinary, international and cross-sectoral perspectives” says Dr. Alan Bernstein, President and CEO of CIFAR. “AI is being adopted around the world. It’s critical that we develop new ways to understand what the implications are across populations, sectors and disciplines. CIFAR is thrilled to partner with France and the UK to advance understanding on AI in society.”
This new initiative is the second stream of workshops realized through CIFAR’s AI & Society program, which was launched in 2017. The AI & Society program is a key pillar of the CIFAR Pan-Canadian AI Strategy, a $125 millioninvestment from the Government of Canada with the goal of supporting Canada’s leadership in machine learning research and training.
For Antoine Petit, Chairman and CEO of the CNRS, “it is essential to strive to analyse and better understand the potential ethical, social, legal or economic repercussions of artificial intelligence. The CNRS is happy to join forces with the CIFAR and UKRI to contribute to the reflection around these issues.”
“The potential of artificial intelligence is reaching all areas of society and business, so it is crucial that we give due consideration to the social and ethical implications of their greater use,” says UK Research and Innovation Chief Executive, Professor Sir Mark Walport. “The workshops announced today, in partnership with CIFAR and CNRS, will make an important contribution to exploring the impact of artificial intelligence, and generate insights that will inform policy, business and the public.”
The full list of workshops and proposal teams is available here.
AI-Powered Virtual Healthcare Available To Canadians
VirtualMED is partnering with HealthTap, a US-based health technology company, to provide Canadians with easy access to high quality, AI-powered virtual care. No more waiting hours at the emergency room or weeks and months for a doctor’s appointment. VirtualMED members will have fast access to primary care, 24/7, from a team of licensed physicians on any internet-enabled device, complete with an AI symptom checker. If a diagnosis cannot be given through teleconsult, an in-person appointment is available within 24 hours.1
First class care
VirtualMED is physician-owned and registered with the Collège des médecins du Québec to provide healthcare services to Canadians. Powered by HealthTap’s technology, VirtualMED will offer consumers and businesses immediate, virtual access to the VirtualMED team of leading physicians. VirtualMED will provide its members with a complete range of services including diagnostics, referrals, prescriptions, lab results, and treatment plans across Canada and the US. “We are proud to be the first to help Canadians and businesses save precious time and money by offering quick and easy access to our team of physicians through the unique combination of HealthTap’s renowned virtual care app and our brick-and-mortar clinics,” said Dr. Patricia Côté, co-owner of VirtualMED.
VirtualMED will offer packages to businesses directly and through their insurance carriers who wish to provide access to virtual primary healthcare for employees which will reduce costs, save time, and increase satisfaction. Individual and family packages will also be available for all Canadians. Users will have access to VirtualMed’s licensed doctors through an AI-based app which provides personalized, convenient diagnoses and treatment plans. VirtualMED members will also have access to affordable, virtual care when travelling in the US, which can prevent expensive treatment costs. VirtualMED services and app will be available to all Canadians in French and English by the end of 2019.
Health technology leader
HealthTap is a globally renowned health technology company that provides comprehensive access to quality primary healthcare in an engaging, satisfying, and value-packed app. HealthTap’s AI-powered platform personalizes users’ care and enables an instant connection between the members and their doctors. According to Sean Mehra, Chief Strategy Officer at HealthTap, “HealthTap is excited to partner with VirtualMED to overcome the issues that affect Canadian healthcare by implementing HealthTap’s comprehensive consumer healthcare experience, powered by AI and supported by a large, global community of doctors and patients. VirtualMED’s established reputation for delivering quality will now be amplified to be Canada’s exemplary healthcare provider committed to timely access to care for all.”
HealthTap’s technology currently serves employers, insurance companies, health systems, and users around the world with industry-leading results. Businesses see user engagement rates up to 18 times the healthcare industry average. Members and doctors using the app report satisfaction scores 7 or more times greater than stand-alone telemedicine solutions. Because employees use it and enjoy it, HealthTap saves time and money for both businesses and consumers.
Subscribe to PICANTE via Email
Follow us on Facebook
Yara and IBM join forces to transform the future of farming
National Cannabis Month Shines Light on CBD-Infused Hard Candies Like Candy Head’s Products
Kendall Jenner Celebrates Launch of the New Elevated Oral Care Collection MOON
2nd Annual Sarasota Veg Fest
Software AG Launches New Digital Transformation Center in Mumbai
Pegasystems Appoints Christopher Lafond to its Board of Directors
R/GA Ventures partners with leading Oregon organizations to create Venture Studio focused on Enterprise Blockchain solutions
Brazilian Credit Marketplace FinanZero raises USD 11 Million in Series B Round
Consumers Growing Demand for Improved Cryptocurrency Payment Platforms on the Rise
HUAWEI CLOUD AI and Huawei Cellphones Help RFCx to Guard the Rainforest
We Are Announcing Big Plans, Launch of Company Profiles, Own Content Distribution Network, Bespoke PR Distribution Services and Dedicated Tech Conference in Europe
CannaCraft Receives Child-Resistant Certification, Eliminating Millions of Single-Use Plastic Tubes
Datamatics Wins IMC Digital Technology Award 2018 for TruBot and TruAI in Emerging Technology Large Category
New Research Identifies the Technology That Hotel Guests Really Want
Dolcas-Tenshi Bioceuticals Targets Sexual Health with All-natural Fortiquin™ Botanical Formula
Forget Tacos On Tuesdays. Taco Bell® Wants Fans To reBELL And Enjoy Tacos Any Day
Sono Motors to Produce Sion in Sweden
Aurora Cannabis launches search for Canada’s Top Budmaster ™
Kountable CEO Talks with UNOPS Head of Global Innovation and Technology about Its Vital Role in Improving Supply Chain Access at BootstrapLabs AI Conference
Calvin Ayre and Bitcoin SV Groups Back Institutional Exchange, DRIVE Markets
Follow our Tweets
Blockchain3 days ago
Calvin Ayre and Bitcoin SV Groups Back Institutional Exchange, DRIVE Markets
Cannabis4 days ago
How CBD Oil Can Help Relieve Pain and Anxiety
Latest News3 days ago
Enlightened Ice Cream Launches Dairy-Free, Low-Calorie Bars
Fintech7 days ago
Joint Forum of Financial Market Regulators continues work on collaboration and information sharing at its Annual Meeting
Airlines/Aviation 3 days ago
Unbabel supports easyJet to create international customer service ‘super agents’
Blockchain7 days ago
NASCO Partners with Several Healthcare Companies to Form a Consortium Focused on Delivering Breakthrough Technologies for the Healthcare Industry
Blockchain7 days ago
Hyperblock Inc. Announces Delay of Annual Filings, Additions and Changes to Board of Directors, and Transition of Interim Chief Financial Officer
Cannabis7 days ago
Introducing Lab Effects, The Sleeping Giant Of The Cannabis Terpene Industry